ClinicalTrials.Veeva

Menu

Efficacy of Azithromycin Prophylaxis in Preventing Recurrent Acute Sinusitis in Children

M

Mahidol University

Status

Completed

Conditions

Sinusitis

Treatments

Drug: azithromycin
Drug: placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT00944515
394/2551(EC4)

Details and patient eligibility

About

The purpose of this study is to evaluate efficacy of azithromycin prophylaxis in preventing recurrent acute sinusitis in children.

Full description

A Prospective, Randomized, Double-blind, Placebo Controlled Trial of azithromycin in preventing recurrent acute sinusitis in children

Enrollment

40 patients

Sex

All

Ages

5 to 15 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • children between the age of 5 years and 15 years with the diagnosis of recurrent acute sinusitis who are attending the outpatient pediatric department, pediatric allergy clinic, and the ear, nose, throat clinic.

Exclusion criteria

  • patients who have allergic rhinitis, chronic sinusitis, a history of allergic reactions to azithromycin or macrolides, treatments with immunotherapy or IVIG or gentamycin solution or pneumococcal vaccine during study period.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

40 participants in 2 patient groups, including a placebo group

azithromycin
Active Comparator group
Description:
azithrimycin 3 days/week
Treatment:
Drug: azithromycin
placebo
Placebo Comparator group
Description:
placebo 3 days/week
Treatment:
Drug: placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems